KP
GNLX icon

Keel Point’s Genelux GNLX Stock Holding History

Keel Point’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,498
Closed -$55.3K – 520
2025
Q1 		$55.3K Buy
+20,498
New +$76.9K ﹤0.01% 469

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Keel Point's GNLX Position: Q2 2025 in Review

Keel Point sold out of Genelux (GNLX) in Q2 2025, closing a stake of 20,498 shares — an estimated $55.3K sold.

Keel Point first reported a position in GNLX in Q1 2025 and held it in 1 quarter. The position peaked at $55.3K in Q1 2025. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

  • Keel Point reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
  • Keel Point sold 20,498 Genelux shares in Q2 2025, an estimated $55.3K.
  • Keel Point first reported a position in Genelux in Q1 2025 and held it in 1 quarter.
  • Keel Point's Genelux position peaked at $55.3K in Q1 2025.
  • 61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Keel Point's 13F filing for Q2 2025, filed 15 Aug 2025.